Our global influence



Our global influence

Company

regenHU — a three dimensional biotechnology company, exploiting the potential of 3D bioprinting & cell based therapies — is leading the development of biomedical products for regenerative medicine & drug discovery. Based in Fribourg, Switzerland, regenHU is a pioneer and global leader in the field, converging digital manufacturing (3D printing), biomaterials and biotechnology to lead transformational innovations in Healthcare.

 

Since 2007, regenHU has dedicated its engineering skills to assisting the scientific community with their cutting-edge bioprinting solutions. Benefiting from a unique network of global partnerships with leading scientific innovators and industrial players, we are constantly at the forefront of innovation.

 

Value Proposition
regenHU provides leading-edge 3D bioprinting solutions. R&D teams worldwide purchase regenHU’s bioprinting platforms and biomaterials because they provide the greatest flexibility and precision for tissue engineering – such as bone, muscle, tendon, skin, kidney, liver and lung. regenHU enables therapies that are biologically and structurally tailored to each patient’s needs. Step-by-step, these breakthroughs are revolutionizing regenerative medicine, drug discovery and cosmeceutical development. Which healthcare breakthroughs do you want to accomplish?
Ask us how regenHU can help you make them happen!

We provide the tools to enter the
third dimension

PARTNERS ARCHIEVEMENTS

Wake Forest Institute for Regenerative Medicine Young Investigator Award for dr. Miguel Castilho

Miguel Castilho, postdoctoral researcher at the Department of Orthopaedics, UMC Utrecht, Netherlands, and at the Department of Orthopaedic Biomechanics, Eindhoven University of Technology, Netherlands has been awarded the WFIRM Young Investigator Award 2017.

Read more

Engineering Complex Bioarchitectures To Biomimic Nature : A Step Closer To The Development Of Artificial Tissue & Organs

This achievement is the result of significant contribution from the University Medical Center Utrecht and the Istituto Ortopedico Rizzoli

Read more

Using 3D printing to find ways to repair damage in the human body

“Dr. Ivan Minev, research group leader at the BIOTEC/CRTD, has been awarded a Freigeist Fellowship from the VolkswagenStiftung. …”

>> Read the complete article.

Read more

UMC Utrecht and regenHU to develop new bioprinting technology

UTRECHT, 8 July 2016 — Partnering experts in 3D bioprinting with experts in biomanufacturing has resulted in the first melt electrospinning device that incorporates the use of bio-inks. Housed at the Utrecht Biofabrication Facility, this combination of techniques may lead to improved and more accurate 3D bioprinting for therapeutic use.

Read more

Process for 3D bone printing

Scientists at the Science Foundation Ireland-funded AMBER materials science centre, hosted at Trinity College Dublin

Read more

Novartis Innovate with regenHU bioprinting technology

“Der Schweizer Pharmariese Novartis setzt bei der Medikamentenentwicklung auf einen 3D-Biodrucker. Die Technologie könnte die Anzahl Tierversuche künftig verringern.

Read more

U.Va. Acquires High-End Bioprinters for Tissue, Organ Fabrication

“The University of Virginia has acquired two new state-of-the-art three-dimensional bioprinters and has begun training lab scientists and bioengineers to “print” tissues that could eventually be used to treat patients with illnesses and injuries ranging from burns to diabetes, and heart, liver and kidney failure.

Read more

Une alternative à l’expérimentation animale a peut-être été trouvée

“L’Institut Adolphe Merkle de Fribourg vient de mettre au point une technique pour imprimer des tissus de poumons à partir de cellules humaines.”

>> See th video…

Read more

3d-skrivaren printar ut framtidens organ

“Brosk till ett skadat knä, ett nytt öra eller en lever. Framtidens mänskliga reservdelar kommer direkt ur 3d-skrivaren. Chalmers har just fått sin första. Men det kommer att ta minst tio år innan utskrivna organ kan opereras in i patienter. …”

Read the complete article…

Read more

Innovation in Skin printing

“Haut aus dem Drucker
Epithel aus dem Labor soll Tierversuche ersetzen: Forscher um die Biochemiker Ursula Graf-Hausner von der Zürcher Hochschule für angewandte Wissenschaften drucken Haut – ihre “Tinte” sind menschliche Zellen.”

See the video.

Read more


Our customers
our best references

001
002
003
004
005
006
007
008
009
010
011
012
013
014
015
016
017
018
019
020
021
022
023
024
025
026
027
028
029
030

 

…And many more

Award

regenHU would once again like to promote a new generation of biotechnological scientists with their “regenHU Young Scientist Award”.

Further information and conditions for participation will be revealed in December 2017. Our appointed committee of experts will reward the most promising project at the next TERMIS International meeting to be held in Kyoto (Japan) in September 2018.

Introducing the “regenHU Young Scientist Award”

In 2013, regenHU launched the “Young Scientist Award” which recognizes a personal contribution demonstrating a high degree of innovation and creativity in the field of regenerative medicine related to biofabrication technologies.
Biennial award to encourage/promote young Scientists in biofabrication, cash price contribution to your project.
Open to Young Scientists active in Academia, Industry, or starting a new scientific initiative in the field of biofabrication.
Applications in English presenting original works that contribute to the advancement of biofabrication. Research dissertations, project descriptions, or practical experience may be included.
The winner will be selected by an international jury of Scientists and Industry leaders.

Award Selection Committee

regenHU promotes scientific advancements that have the potential to bring a significant enhancement / tool to the healthcare world. Our mission is to create bridges between the scientific, academia and industrial environments “from the Lab to the Market”.

The distinguished selection committee was chosen based on the above philosophy, it comprises of 5 leaders with strong scientific and/or industrial backgrounds. The committee members are opinion leaders in the biofabrication environment either as user or as innovator.

Scientific Committee

Prof. Ernst Reichmann, PhD

Prof.   Ernst  Reichmann, PhDUniversity of Zürich, Switzerland

Prof. Daniel J. Kelly

Prof. Daniel J. KellyTrinity College Dublin, Ireland

Industrial Committee

Dr. Hansjoerg Keller

Dr. Hansjoerg KellerNovartis Institute for BioMedical Research
Basel, Switzerland

Dr. Paulo Marinho

Dr. Paulo MarinhoL’Oréal SA
Paris, France

Thurner Marc

Thurner MarcregenHU Ltd
Fribourg, Switzerland